FR2388814A1 - 9-Amino-de:oxy-clavulanic acid and acylated derivs. - antibacterials and beta-lactamase inhibitors - Google Patents
9-Amino-de:oxy-clavulanic acid and acylated derivs. - antibacterials and beta-lactamase inhibitorsInfo
- Publication number
- FR2388814A1 FR2388814A1 FR7812329A FR7812329A FR2388814A1 FR 2388814 A1 FR2388814 A1 FR 2388814A1 FR 7812329 A FR7812329 A FR 7812329A FR 7812329 A FR7812329 A FR 7812329A FR 2388814 A1 FR2388814 A1 FR 2388814A1
- Authority
- FR
- France
- Prior art keywords
- cor8
- clavulanic acid
- cor4
- esp
- antibacterials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Clavulanic acid derivs. of formula (I) are new: A is H, salt forming cation or ester gp. R1 is H, CO2R3, COR4 or OR5, R2 is H, CO2R7 or COR8. R3, R4, R7 and R8 are lower alkyl or alkenyl, lower alkylaryl or aryl, R5 is CO2R6, COR6 or SO2R6, R6 is as R3. When R1 is COR4 and R2 is COR8, R4+R8 can combine so that N(COR4)COR8 is a 5-7 membered heterocycle opt. condensed to a benzene ring which can be substd. by 1 or 2, lower alkyl or alkoxy, F or Cl. Also, when R1 is OR5 and R2 is COR8, R5+R8 can combine so that N(OR5)COR8 is a 5-7 membered heterocycle. They are made by reacting a clavulanic acid ester with HNR1'R2' (R1' and R2' as R1 and R2 but not H), R14OCO.N=N.COOR15 (R14 and R15 = alkyl, alkaryl or aryl) and e.g. a trialkyl phosphite. (I) are antibacterials and inhibitors of beta-lactamase produced by Gram positive and negative bacteria. They can be used alone or esp. combined with another cephalosporin or penicillin (specifically amoxycillin or ampicillin) at ratio (I) other antibiotic of 3:1-1:10 esp. 1:1-1:8. They are esp. useful for treating infections of the respiratory and urinary tracts, or of the soft tissues, and for treating mastitis in cattle.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB17660/77A GB1603208A (en) | 1977-04-27 | 1977-04-27 | Aminodeoxyclavulanic acid and acyl derivatives threreof |
GB3283577 | 1977-08-05 | ||
GB4793477 | 1977-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2388814A1 true FR2388814A1 (en) | 1978-11-24 |
Family
ID=27257530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7812329A Withdrawn FR2388814A1 (en) | 1977-04-27 | 1978-04-26 | 9-Amino-de:oxy-clavulanic acid and acylated derivs. - antibacterials and beta-lactamase inhibitors |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2388814A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997010247A1 (en) * | 1995-09-15 | 1997-03-20 | Smithkline Beecham P.L.C. | Clavulanic acid derivatives for treating atherosclerosis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2353556A1 (en) * | 1976-06-04 | 1977-12-30 | Glaxo Lab Ltd | CLAVULANIC ACID DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC APPLICATION |
US4078067A (en) * | 1976-04-12 | 1978-03-07 | Merck & Co., Inc. | 3-(.beta.-Aminoethylidene)-7-oxo-4-oxaazabicyclo[3.2.0]heptane-2-carboxylic acid and derivatives thereof |
-
1978
- 1978-04-26 FR FR7812329A patent/FR2388814A1/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4078067A (en) * | 1976-04-12 | 1978-03-07 | Merck & Co., Inc. | 3-(.beta.-Aminoethylidene)-7-oxo-4-oxaazabicyclo[3.2.0]heptane-2-carboxylic acid and derivatives thereof |
FR2353556A1 (en) * | 1976-06-04 | 1977-12-30 | Glaxo Lab Ltd | CLAVULANIC ACID DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC APPLICATION |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997010247A1 (en) * | 1995-09-15 | 1997-03-20 | Smithkline Beecham P.L.C. | Clavulanic acid derivatives for treating atherosclerosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2000138A (en) | Therapeutic agents | |
ES452361A1 (en) | Process for manufacture of 9-amino-9-deoxyclavulanates | |
ES476856A1 (en) | Penicillins, per se and for use as antibacterially active antibiotics and their production. | |
FR2388814A1 (en) | 9-Amino-de:oxy-clavulanic acid and acylated derivs. - antibacterials and beta-lactamase inhibitors | |
IT1156890B (en) | 9-Amino-de:oxy-clavulanic acid and acylated derivs. - antibacterials and beta-lactamase inhibitors | |
NL7807413A (en) | 9-Amino-de:oxy-clavulanic acid and acylated derivs. - antibacterials and beta-lactamase inhibitors | |
SE7713901L (en) | TIOOXIMCEPHALOSPORIN AND PENICILLIN DERIVATIVES | |
ES442217A1 (en) | 1,4-Dihydro-4-oxo-pyridylacetamido cephalosporins and their utilization as medicinal agents for combating bacterial infections | |
ES461691A1 (en) | Beta-lactam antibiotics | |
ES469182A1 (en) | Antibacterial agents | |
GB1390754A (en) | Penicillin and cephalosporin esters | |
FR2285134A1 (en) | 7-(2-(4-hydroxy-3-nitrophenyl)-2-aminoacetamido)-cephalosporins - with broad-spectrum antibacterial activity | |
NL7601632A (en) | Antibacterial 1,8-naphthyridine derivs - viz. 7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acids, by ylid hydrolysis | |
FR2336130A1 (en) | Antibacterial deoxy-clavulanic and isodeoxy-clavulanic acids - antibacterials used in treating urinary tract infections respiratory, illness, non-muscular tissue infections etc. | |
FR2372630A1 (en) | Antibacterial cephalosporin type cpds - eg 7-beta-(substd-acetamido)-3-(3-heterocyclyl prop-1-enyl)-ceph-3-em-4-carboxylic acids | |
ES476259A1 (en) | Penicillanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
FR2429221A1 (en) | 3-Carbamoyloxy:methyl cephalosporin antibiotics prodn. - from 3-hydroxymethyl cpd. and di:halo-phosphinyl isocyanate, and new intermediates | |
GB1074331A (en) | Penicillins | |
GB1476432A (en) | Pharmaceutical compositions containing penicillin salts | |
FR2264019A1 (en) | Penicillins and cephalosporins prepn. - from amino penicillanic acids or cephemes and a mixed anhydride and hydrolysing | |
ES441744A1 (en) | Cephalosporin derivatives, and compositions containing them | |
GB1477672A (en) | Penicillin compositions | |
GB1476312A (en) | Penicillins and cephalosporins | |
FR2375240A1 (en) | 1,2,4-Thiazolidine 1,1-di:oxide penicillin and cephalosporin derivs. - with antibacterial and growth-promoting activity | |
ES452779A1 (en) | 7-(alpha-(2-oxo-imidazolidin-1-yl-carbonylamino)-phenylacetamido)-cephalosporins processes for their preparation and their use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |